E2F1 and prostate carcinoma: In a previous study, we found that in prostate cancer, MAGE-A11 is a proto-oncogene, the increased expression of which reverses retinoblastoma-related protein p107 from a transcriptional repressor to a transcriptional activator of the AR and E2F1 16.